The Oncology Institute, Inc. (TOI) Q1 2025 Earnings
TOI·Reported May 14, 2025·After market close
The Oncology Institute, Inc. reported Q1 2025 revenue of $104.4M (+10.3% YoY). Diluted EPS came in at $-0.17 (+22.7% YoY).
Revenue
$104.4M
Diluted EPS
$-0.17
Financial Snapshot
Trailing eight quarters through Q1 2025
Q1 2025 Earnings FAQ
Common questions about The Oncology Institute, Inc.'s Q1 2025 earnings report.
The Oncology Institute, Inc. (TOI) reported Q1 2025 earnings on May 14, 2025 after market close.
The Oncology Institute, Inc. reported revenue of $104.4M and diluted EPS of $-0.17 for Q1 2025.
Compared to the same quarter a year prior, revenue grew 10.3% from $94.7M a year earlier and diluted EPS grew 22.7% from $-0.22.
You can read the 10-Q periodic report (0001628280-25-025507) directly on SEC EDGAR. The filing index links above go to sec.gov.